Minocycline protects developing brain against ethanol-induced damage

Neuropharmacology. 2018 Feb:129:84-99. doi: 10.1016/j.neuropharm.2017.11.019. Epub 2017 Nov 14.

Abstract

Fetal alcohol spectrum disorders (FASD) are caused by ethanol exposure during the pregnancy and is the leading cause of mental retardation. Ethanol exposure during the development results in the loss of neurons in the developing brain, which may underlie many neurobehavioral deficits associated with FASD. It is important to understand the mechanisms underlying ethanol-induced neuronal loss and develop appropriate therapeutic strategies. One of the potential mechanisms involves neuroimmune activation. Using a third trimester equivalent mouse model of ethanol exposure, we demonstrated that ethanol induced a wide-spread neuroapoptosis, microglial activation, and neuroinflammation in C57BL/6 mice. Minocycline is an antibiotic that inhibits microglial activation and alleviates neuroinflammation. We tested the hypothesis that minocycline may protect neurons ethanol-induced neuron death by inhibiting microglial activation and neuroinflammation. We showed that minocycline significantly inhibited ethanol-induced caspase-3 activation, microglial activation, and the expression of pro-inflammatory cytokines. In contrast, minocycline reversed ethanol inhibition of anti-inflammatory cytokines. Minocycline blocked ethanol-induced activation of GSK3β, a key mediator of neuroinflammation and microglial activation in the developing brain. Consistent with the in vivo observations, minocycline inhibited ethanol-induced the expression of pro-inflammatory cytokines and activation of GSK3β in a microglia cell line (SIM-9). GSK3β inhibitor eliminated ethanol activation of pro-inflammatory cytokines in SIM-9 cells. Co-cultures of cortical neurons and SIM-9 microglia cells sensitized neurons to alcohol-induced neuronal death. Minocycline protected neurons against ethanol-induced neuronal death in neurons/microglia co-cultures. Together, these results suggest that minocycline may ameliorate ethanol neurotoxicity in the developing by alleviating GSK3β-mediated neuroinflammation.

Keywords: Apoptosis; Development; Fetal alcohol syndrome; Inflammation; Microglia; Neurodegeneration.

MeSH terms

  • Animals
  • Animals, Newborn
  • Brain Injuries / chemically induced
  • Brain Injuries / drug therapy*
  • Brain* / drug effects
  • Brain* / growth & development
  • Brain* / metabolism
  • CREB-Binding Protein / genetics
  • CREB-Binding Protein / metabolism
  • Calcium-Binding Proteins / metabolism
  • Caspase 3 / metabolism
  • Cells, Cultured
  • Central Nervous System Depressants / toxicity
  • Cerebral Cortex / cytology
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Encephalitis / drug therapy*
  • Enzyme Inhibitors / therapeutic use
  • Ethanol / toxicity
  • Glycogen Synthase Kinase 3 beta / genetics
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Microfilament Proteins / metabolism
  • Microglia / drug effects
  • Minocycline / therapeutic use*
  • Neurons / drug effects
  • Neuroprotective Agents / therapeutic use*
  • Signal Transduction / drug effects

Substances

  • Aif1 protein, mouse
  • Calcium-Binding Proteins
  • Central Nervous System Depressants
  • Cytokines
  • Enzyme Inhibitors
  • Microfilament Proteins
  • Neuroprotective Agents
  • Ethanol
  • CREB-Binding Protein
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Caspase 3
  • Minocycline